-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Positron Emitting Tomography Contrast Agents · Magnetic Resonance Imaging (MRI) Contrast Agents · Gadolinium-based MRI Contrast Agents...
-
Company Profile
Adamas Pharmaceuticals Inc – Company Profile
Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) discovers, develops and markets therapeutics for treatment of neurological diseases. The company's Gocovri is an amantadine extended-release capsule for the treatment for dyskinesia in patients with Parkinson’s disease. Gocovri is a high-dose, once-daily indication designed to deliver a high level of amantadine in the morning and throughout the day when dyskinesia occurs. It also offers Namenda XR and Namzaric capsules for the treatment of moderate to severe Alzheimer’s dementia disease under an exclusive license agreement...
Add to Basket -
Product Insights
Dyskinesia Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2019" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Tardive Dyskinesia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H2, 2018" provides an overview of Tardive Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Tardive Dyskinesia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Parkinson’s Disease Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H1, 2018" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Parkinson's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Partial Seizure Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H1, 2018" provides an overview of Partial Seizure clinical trials scenario. This report provides top line data relating to the clinical trials on Partial Seizure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Multiple Sclerosis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H1, 2018" provides an overview of Multiple Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Sclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
PharmaPoint: Alzheimer’s Disease – Global Drug Forecast and Market Analysis to 2026
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by impaired memory and thinking (known as dementia), and functional decline. With a rapidly accelerating worldwide prevalence, there is a growing societal pressure for curative treatment for AD patients. The burden of AD encompasses clinical burden to patients as well as economic burden to payers and patients and caregiver burden, adding to the urgent need for improved AD therapy. Significant efforts are being made to develop a new treatment...
-
Product Insights
Dyskinesia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H2, 2017" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Parkinson’s Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H2, 2016" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Parkinson's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...